{"bill":{"id":"119-hr-2343","congress":119,"type":"HR","number":2343,"title":"John W. Walsh Alpha-1 Home Infusion Act of 2025","originChamber":"House","introducedDate":"2025-03-25","sponsors":[{"bioguideId":"S000168","fullName":"Rep. Salazar, Maria Elvira [R-FL-27]","party":"R","state":"FL","district":27}],"cosponsorsCount":49,"latestAction":{"actionDate":"2025-03-25","text":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned."},"policyArea":"Health","subjects":[],"actions":[{"date":"2025-03-25","text":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","type":"IntroReferral","chamber":"House floor actions","hasVote":false},{"date":"2025-03-25","text":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","type":"IntroReferral","chamber":"House floor actions","hasVote":false},{"date":"2025-03-25","text":"Introduced in House","type":"IntroReferral","chamber":"Library of Congress","hasVote":false},{"date":"2025-03-25","text":"Introduced in House","type":"IntroReferral","chamber":"Library of Congress","hasVote":false}],"summary":"<p><strong>John W. Walsh Alpha-1 Home Infusion Act of 2025</strong><strong></strong></p><p>This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.</p>","updateDate":"2026-03-25T08:05:41Z"},"markets":[],"stateBills":[],"meta":{"sources":["congress.gov"],"latencyMs":317,"ts":"2026-04-19T08:35:13.945Z"},"nextActions":{"inspect":[],"related":[{"description":"Search related legislation","method":"GET","url":"/api/public/query-gov?q=John%20W.%20Walsh%20Alpha-1%20Home%20Infusion%20Act%20of%202025"}]}}